Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-09

Clinical Trial Update: Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing combination chemotherapy with or without cetuximab in stage III colon cancer completely resected by surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetuximab (cetuximab)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED